Welcome to JCTH

Table of Contents

Editorial

Recommendations and Clinical Guidance for Children with Metabolic-associated Fatty Liver Disease during the COVID-19 Pandemic
Yong-Hai Zhou, Rafael S. Rios, Kenneth I. Zheng, Ming-Hua Zheng
[ Abstract ] [ Html ] [ PDF Full-text ] 1-2 Doi: 10.14218/JCTH.2020.00137

Original Article

Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease
Shousheng Liu, Jianhan Xiao, Zhenzhen Zhao, Mengke Wang, Yifen Wang, Yongning Xin
[ Abstract ] [ Html ] [ PDF Full-text ] 3-14 Doi: 10.14218/JCTH.2020.00081

HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters
Muhammad Masroor, Zeba Haque
[ Abstract ] [ Html ] [ PDF Full-text ] 15-21 Doi: 10.14218/JCTH.2019.00046

A Deep Look into the Program of Rapid Tumor Growth of Hepatocellular Carcinoma
Jie Wang, Yi Lou, Jianmin Lu, Yuxiao Luo, Anqian Lu, Anna Chen, Jiantao Fu, Jing Liu, Xiang Zhou, Jin Yang
[ Abstract ] [ Html ] [ PDF Full-text ] 22-31 Doi: 10.14218/JCTH.2020.00084

Bacterial Infections in Cirrhotic Patients in a Tertiary Care Hospital
Vivek A. Lingiah, Nikolaos T. Pyrsopoulos
[ Abstract ] [ Html ] [ PDF Full-text ] 32-39 Doi: 10.14218/JCTH.2020.00076

Review Article

Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
Mithun Sharma, Madhumita Premkumar, Anand V Kulkarni, Pramod Kumar, D Nageshwar Reddy, Nagaraja Padaki Rao
[ Abstract ] [ Html ] [ PDF Full-text ] 40-50 Doi: 10.14218/JCTH.2020.00055

New Drugs on the Block—Emerging Treatments for Nonalcoholic Steatohepatitis
Sanja Stojsavljevic-Shapeski, Marko Duvnjak, Lucija Virovic-Jukic, Davor Hrabar, Lea Smircic Duvnjak
[ Abstract] [ Html ] [ PDF Full-text ] 51-59 Doi: 10.14218/JCTH.2020.00057

An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents
Vinka Rupcic Rubin, Kristina Bojanic, Martina Smolic, Jurica Rubin, Ashraf Tabll, Robert Smolic
[ Abstract ] [ Html ] [ PDF Full-text ] 60-70 Doi: 10.14218/JCTH.2020.00040

Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
Ma Ai Thanda Han, Qi Yu, Zaid Tafesh, Nikolaos Pyrsopoulos
[ Abstract ] [ Html ] [ PDF Full-text ] 71-80 Doi: 10.14218/JCTH.2020.00082

Noncanonical NF-κB Signaling Pathway in Liver Diseases
Qianhui Chen, Xinyu Lu, Xiaoyong Zhang
[ Abstract ] [ Html ] [ PDF Full-text ] 81-89 Doi: 10.14218/JCTH.2020.00063

Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis
Qiaoling Wang, Binxia Chang, Xiaoyan Li, Zhengsheng Zou
[ Abstract] [ Html ] [ PDF Full-text ] 90-98 Doi: 10.14218/JCTH.2020.00104

An Ecological Evaluation of Vinyl Chloride Exposure and Liver Cancer Incidence and Mortality in Texas
Kevin M. Towle, Stacey M. Benson, Natalie S. Egnot, Gary M. Marsh
[ Abstract] [ Html ] [ PDF Full-text ] 99-105 Doi: 10.14218/JCTH.2020.00073

Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts
Teresa Da Cunha, George Y. Wu
[ Abstract] [ Html ] [ PDF Full-text ] 106-115 Doi: 10.14218/JCTH.2020.00088

Celiac Disease and Elevated Liver Enzymes: A Review
Jaimy Villavicencio Kim, George Y. Wu
[ Abstract] [ Html ] [ PDF Full-text ] 116-124 Doi: 10.14218/JCTH.2020.00089

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection
Xiaoqing Liu, Peng Hu
[ Abstract] [ Html ] [ PDF Full-text ] 125-132 Doi: 10.14218/JCTH.2020.00078

Case Report

Chronic Active Hepatitis B with COVID-19 in Pregnancy: A Case Report
Qiu-Yu Li, Zhuo-Yu An, Chao Li, Ming Zu, Lei Chen, Jia-Nan Zhang, Yang-Yu Zhao, Ning Shen, Qing-Gang Ge
[ Abstract ] [ Html ] [ PDF Full-text ] 133-135 Doi: 10.14218/JCTH.2020.00085

Occult Hepatitis B Reactivation after Liver Transplant: The Role of a Novel Mutation in the Surface Antigen
Harjot K. Bedi, Daljeet Chahal, Christopher F. Lowe, Gordon Ritchie, Trana Hussaini, Vladimir Marquez, Eric M. Yoshida
[ Abstract] [ Html ] [ PDF Full-text ] 136-138 Doi: 10.14218/JCTH.2020.00090